Stock name 27th closing price ⇒ Change from the previous day.

Sumitomo Pharma <4506> 583 -20

Morgan Stanley continues to recommend selling at MUFG Securities.

Double Scope <6619> 296 -12

The trend of negative views on business performance forecasts continues.

Ricoh <7752> 1663 -89

Nomura Securities has downgraded its investment rating.

Sakura Internet <3778> 4855 -0

Awareness of the heaviness of the upper levels around 5000 yen.

Japan Micro Devices <6871> 3885 -30

Selling is leading due to the decline of the SOX index on the 27th.

ZOZO <3092> 4757 -98

Rebound with an increase up to the level of the 25-day moving average may feel completed.

Dexerials <4980> 2417.5 -29.5

Selling to cover positions below the 25-day moving average may be dominant.

Net Pro HD <7383> 408 -16

A heavy upper price is leading to a dominant sell-off by short-term capital.

Okamoto Glass <7746> 167 +50.

Established a mass production system for aluminum nitride ceramic substrates.

Sumishin SBI Net Bank <7163> 3405 +500.

Acquisition speculation by Docomo is being viewed as a possibility.

Urbanet <3242> 440 +60.

The announcement of shareholder incentives increases the allure of the yield.

Flight <3753> 169 -9.

The credit card payment center has started non-face-to-face transactions.

Wellnet <2428> 888 +50

Collaborating with Japan Communications to build electronic money with identity verification.

Abalance <3856> 859 -104

The stock price of the NASDAQ-listed subsidiary surged significantly on the 27th.

Soketsu <3634> 683 -67

A significant rise on the 27th due to favorable business collaboration with affiliated artist Horipro.

First Brothers <3454> 1073 -102

In November, the impact of rights expiration leads to a strong tendency for sell-offs.

F-Brain <3927> 740 +41

The security diagnostic service has been adopted by the Chiba Prefecture Ichihara City Office.

Triple Eyes <5026> 1256 -35

Announced the policy on the holding of cryptocurrency at the group company Zero Field.

Buying does not continue.

DELTA-P <4598> 490 -39

Afatinib is recommended in the "Lung Cancer Treatment Guidelines 2024 Edition" by the Japan Lung Cancer Society.

It was announced that it has been recognized as a treatment method, gaining popularity on the 27th. On the 28th, selling was dominant.

AViC <9554> 1140 +58

It was announced that the joint venture in china has received its first order and will record its revenue.

Chordia <190A> 276 -20

It is expected to present research results on CDK12 inhibitors at the japan Molecular Biology Society, gaining popularity on the 27th.

On the 28th, there was a mix of buying and selling.

Rain Wind Sun <5616> 1250 +101

There continues to be a focus on the appointment of representative Takahashi as a member of the new local economy and living environment revitalization meeting.

GNI <2160> 3070 +117.

Responded that "the rise in the stock price of the reverse merger target of the consolidated subsidiary has also significantly increased the stock evaluation profit."

It was bought on the 27th. Buying remained strong on the 28th.

Shinmene <6086> 1538 +24.

Announced a share buyback and purchase commission of up to 1.87% of the issued shares.

TrueData <4416> 465 +2.

Gained popularity on the 27th due to a basic agreement with Tokio Marine Smart Mobility.

On the 28th, there was a mix of buying and selling.

ZETA <6031> 387 -16

Revised upward the financial estimates for revenue and net profit for the fiscal year ending December 2024. Grew popular for a while but then stalled.